期刊： CARDIOVASCULAR RESEARCH, 2022; 118 (5)
Aims The goal of our study was to investigate the heterogeneity of cardiac macrophages (CM phi s) in mice with transverse aortic constriction (TAC) vi......
期刊： CARDIOVASCULAR RESEARCH, 2022; 118 (9)
Aims The heart undergoes pathological remodelling under increased stress and neuronal imbalance. MicroRNAs (miRNAs) are involved in post-transcription......
期刊： CARDIOVASCULAR RESEARCH, 2022; 118 (7)
Aims The clinical use of antitumour agent doxorubicin (DOX) is hampered by its dose-dependent cardiotoxicity. Development of highly efficient and safe......
期刊： CARDIOVASCULAR RESEARCH, 2022; 118 (8)
Aims Recent studies have shown that the choline-derived metabolite trimethylamine N-oxide (TMAO) is a biomarker that promotes cardiovascular disease t......
期刊： CARDIOVASCULAR RESEARCH, 2022; 118 (1)
CD36, also known as the scavenger receptor B2, is a multifunctional receptor widely expressed in various organs. CD36 plays a crucial role in the upta......
期刊： CARDIOVASCULAR RESEARCH, 2022; 118 (3)
Aims Ageing is the most significant contributor to the increasing prevalence of atrial fibrillation (AF). The gut microbiota dysbiosis is involved in ......
期刊： CARDIOVASCULAR RESEARCH, 2022; 118 (9)
Aims Interleukin (IL)-5 mediates the development of eosinophils (EOS) that are essential for tissue post-injury repair. It remains unknown whether IL-......
期刊： CARDIOVASCULAR RESEARCH, 2022; 118 (3)
Aims Congenital heart disease (CHD) frequently occurs in newborns due to abnormal formation of the heart or major blood vessels. Mutations in the GATA......
期刊： CARDIOVASCULAR RESEARCH, 2022; 118 (1)
Vasculopathy is a pathological process occurring in the blood vessel wall, which could affect the haemostasis and physiological functions of all the v......
期刊： CARDIOVASCULAR RESEARCH, 2022; 118 (12)
Aims Remdesivir is a prodrug of an adenosine triphosphate analogue and is currently the only drug formally approved for the treatment of hospitalized ......
期刊： CARDIOVASCULAR RESEARCH, 2022; 118 (13)
Aims Abnormal intracellular calcium (Ca2+) handling contributes to the progressive nature of atrial fibrillation (AF), the most common sustained cardi......
期刊： CARDIOVASCULAR RESEARCH, 2022; 118 (2)
Aims Fibroblast growth factor (FGF) 21, a key regulator of energy metabolism, is currently evaluated in humans for treatment of type 2 diabetes and no......
期刊： CARDIOVASCULAR RESEARCH, 2022; 118 (10)
Aims Concern about the cardiovascular safety of coronavirus disease 2019 (COVID-19) vaccines among individuals with cardiovascular disease (CVD) may l......
期刊： CARDIOVASCULAR RESEARCH, 2022; 118 (3)
Aims Macrophage-mediated inflammatory response represents a key pathophysiological process in a host of cardiovascular diseases including heart failur......
期刊： CARDIOVASCULAR RESEARCH, 2022; 118 (6)
Aims Acute aortic dissection (AAD) is a life-threatening disease with high morbidity and mortality. Previous studies have showed that vascular smooth ......
